Rating History for Neoleukin Therapeutics (NLTX) by H.C. Wainwright

More Stocks Rated by H.C. Wainwright | Latest Ratings for NLTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/16/2022 Robert Burns Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.42
(3.49)		 730.95% Details